Published Paper Details:

Endometrial hyperplasia (EH), a precursor to endometrial cancer, manifests as abnormal uterine bleeding (AUB) characterized by irregular cycles, heavy menstrual flow, and prolonged bleeding. This review evaluates Ayurvedic interventions for managing EH, focusing on their efficacy, treatment protocols, and outcomes. The review consolidates data from multiple case studies, highlighting the use of Ayurvedic formulations, including Pushyanuga Churna, Dashmool Kwatha, Ashokarishta, and Chandanasava. Treatments incorporated internal medications, external therapies like Basti (medicated enemas), and vaginal applications. Across cases, significant reductions in endometrial thickness (from 9.1-20.1 mm pre-treatment to 3.7-7 mm post-treatment) were observed. Patients experienced normalization of menstrual cycles, reduced bleeding (e.g., from 12 pads/day to 2-3 pads/day), and alleviation of associated symptoms such as pain and fatigue. Therapy durations ranged from 1 to 16 months, with consistent improvement in both structural and symptomatic aspects of EH. These findings underscore the effectiveness and safety of Ayurvedic treatments in reversing hyperplasia and improving quality of life, emphasizing a holistic approach that combines internal and external therapies.